2001
DOI: 10.1106/7lv0-amkg-kefg-vyh0
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Characterization of New Functional Polyelectrolytes Based on Carboxyl Containing Methacrylates

Abstract: Three new methacrylic monomers, 6-methacryloyloxyhexanoic acid, 6-(N-methacryloyl)aminohexanoic acid, and ethyl 6-(N-methacryloyl)-aminohexanoate, containing carboxyl groups spaced from the polymerizable double bond by a polymethylene chain, have been synthesized. Multifunctional polymeric materials were obtained by radical polymerization of these monomers with different vinyl monomers. The type and content of the functional groups was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…9 10 These receptors can recognize the galactose units on the oligosaccharide chains of glycoproteins or on chemically galactosylated drug carriers. 11 In the framework of a long-standing activity in the development of biocompatible polymers for biomedical and tissue engineering applications, [12][13][14][15][16][17][18][19][20][21] in a previous paper 18 we reported the formulations of nanoparticles loaded with -interferon ( -IFN), a proteic drug widely used in the treatment of hepatitis C. These carriers were prepared in order to achieve targeted and controlled delivery of -IFN to hepatocytes, the liver parenchymal cells that are affected by hepatitis C viral infection. To the best of our knowledge, no previous report on the targeted delivery of drugs to liver hepatocytes by biodegradable nanoparticles is present in the literature.…”
Section: Introductionmentioning
confidence: 99%
“…9 10 These receptors can recognize the galactose units on the oligosaccharide chains of glycoproteins or on chemically galactosylated drug carriers. 11 In the framework of a long-standing activity in the development of biocompatible polymers for biomedical and tissue engineering applications, [12][13][14][15][16][17][18][19][20][21] in a previous paper 18 we reported the formulations of nanoparticles loaded with -interferon ( -IFN), a proteic drug widely used in the treatment of hepatitis C. These carriers were prepared in order to achieve targeted and controlled delivery of -IFN to hepatocytes, the liver parenchymal cells that are affected by hepatitis C viral infection. To the best of our knowledge, no previous report on the targeted delivery of drugs to liver hepatocytes by biodegradable nanoparticles is present in the literature.…”
Section: Introductionmentioning
confidence: 99%